Literature DB >> 15166304

Insulin sensitivity, body fat distribution, and family diabetes history: the IRAS Family Study.

Braxton D Mitchell1, Daniel Zaccaro, Lynne E Wagenknecht, Ann L Scherzinger, Richard N Bergman, Steven M Haffner, John Hokanson, Jill M Norris, Jerome I Rotter, Mohammed F Saad.   

Abstract

OBJECTIVE: Markers of insulin resistance are often apparent in nondiabetic relatives of subjects with type 2 diabetes. Whether diabetes family history (FH) also predicts visceral fat accumulation and, if so, whether the increased insulin resistance in relatives of diabetic subjects occurs independently of visceral fat accumulation are not known. RESEARCH METHODS AND PROCEDURES: To examine this issue, we studied the relationship of diabetes FH with insulin sensitivity and fat measures, measured by minimal model analysis and computed tomography, respectively, in families participating in the Insulin Resistance Atherosclerosis (IRAS) Family Study. FH scores were based on the diabetes status of the participants' parents and older siblings.
RESULTS: FH scores were significantly correlated with reduced insulin sensitivity (p < 0.05) and increased subcutaneous (p < 0.05) and visceral (p < 0.05, San Antonio only) fat in families from San Antonio and Los Angeles but not in the leaner Hispanic families from San Luis Valley. There was no evidence for a stronger association of FH score with visceral fat accumulation than with subcutaneous fat or insulin resistance. DISCUSSION: The absence of an association between FH score and insulin resistance/fat accumulation in San Luis Valley is consistent with the idea that the expression of transmitted diabetes genes may be suppressed in leaner, more physically active populations. Copyright 2004 NAASO

Entities:  

Mesh:

Year:  2004        PMID: 15166304     DOI: 10.1038/oby.2004.100

Source DB:  PubMed          Journal:  Obes Res        ISSN: 1071-7323


  7 in total

Review 1.  Understanding the growing epidemic of type 2 diabetes in the Hispanic population living in the United States.

Authors:  Cristina Aguayo-Mazzucato; Paula Diaque; Sonia Hernandez; Silvia Rosas; Aleksandar Kostic; Augusto Enrique Caballero
Journal:  Diabetes Metab Res Rev       Date:  2018-12-04       Impact factor: 4.876

2.  Metabolic dysfunction in women with bipolar disorder: the potential influence of family history of type 2 diabetes mellitus.

Authors:  Natalie L Rasgon; Heather A Kenna; Margaret F Reynolds-May; Pascale G Stemmle; Mytilee Vemuri; Wendy Marsh; Po Wang; Terence A Ketter
Journal:  Bipolar Disord       Date:  2010-08       Impact factor: 6.744

3.  Visceral fat and prevalence of hypertension among African Americans and Hispanic Americans: findings from the IRAS family study.

Authors:  Capri G Foy; Fang-Chi Hsu; Steven M Haffner; Jill M Norris; Jerome I Rotter; Leora F Henkin; Michael Bryer-Ash; Yii-Der I Chen; Lynne E Wagenknecht
Journal:  Am J Hypertens       Date:  2008-06-19       Impact factor: 2.689

4.  Family history of diabetes, awareness of risk factors, and health behaviors among African Americans.

Authors:  Kesha Baptiste-Roberts; Tiffany L Gary; Gloria L A Beckles; Edward W Gregg; Michelle Owens; Deborah Porterfield; Michael M Engelgau
Journal:  Am J Public Health       Date:  2007-03-29       Impact factor: 9.308

5.  Height, ethnicity, and the incidence of diabetes: the San Antonio Heart Study.

Authors:  Carlos Lorenzo; Ken Williams; Michael P Stern; Steven M Haffner
Journal:  Metabolism       Date:  2009-07-07       Impact factor: 8.694

6.  Family history of type 2 diabetes, abdominal adipocyte size and markers of the metabolic syndrome.

Authors:  P Anthanont; P Ramos; M D Jensen; K C Hames
Journal:  Int J Obes (Lond)       Date:  2017-07-24       Impact factor: 5.095

7.  The uncoupling protein 1 gene, UCP1, is expressed in mammalian islet cells and associated with acute insulin response to glucose in African American families from the IRAS Family Study.

Authors:  Michèle M Sale; Fang-Chi Hsu; Nicholette D Palmer; Candace J Gordon; Keith L Keene; Hermina M Borgerink; Arun J Sharma; Richard N Bergman; Kent D Taylor; Mohammed F Saad; Jill M Norris
Journal:  BMC Endocr Disord       Date:  2007-03-30       Impact factor: 2.763

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.